RO-14
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO-14, covering 2011-06-08 to 2011-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers [Phase 1]